Where I see patients (2)
Siplizumab in T1DM
Evaluating four siplizumab dosing regimens for induction of a T cell phenotype signature based on the 20% increase or greater from baseline in PD1. The primary analysis will identify siplizumab doses with acceptable safety profile...
Type 1 Diabetes Extension Study
Evaluation of changes in beta cell function over time will be measured by mixed-meal tolerance test (MMTT) -Stimulated mean C-Peptide area under the curve (AUC). C-peptide is released by the pancreas into the bloodstream in equal ...
Smell the roses